Colossal Biosciences is a de-extinction and genetic engineering company aiming to restore lost ecosystems. Leveraging advanced CRISPR technologies and computational biology, Colossal works on editing the genomes of potential proxy species to resurrect phenotypes of the Woolly Mammoth, Thylacine, and Dodo. The company’s platform also advances conservation biology and human healthcare through breakthroughs in multiplex editing and artificial gestation. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.